Biovotion has secured a first close for its series A round, backed by Swiss Re and STMicroelectronics.
Switzerland-based digital health company Biovotion received SFr10m ($10.4m) on Monday in a first close of its series A round led by reinsurance company Swiss Re.
Electronics and semiconductor manufacturer STMicroelectronics also contributed to the round as an existing shareholder, though details about its previous involvement have not been disclosed.
Founded in 2011, Biovotion is developing a clinical-grade wearable monitoring platform for data such as heart rate and blood oxygenation. The platform helps users maintain a healthy lifestyle or manage a…
